177A Stock Overview
Manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Kohjin Bio Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,632.00 |
| 52 Week High | JP¥3,065.00 |
| 52 Week Low | JP¥1,281.00 |
| Beta | 0 |
| 1 Month Change | -7.01% |
| 3 Month Change | -6.74% |
| 1 Year Change | -1.39% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -31.14% |
Recent News & Updates
Shareholder Returns
| 177A | JP Biotechs | JP Market | |
|---|---|---|---|
| 7D | -11.6% | 6.0% | -1.1% |
| 1Y | -1.4% | 29.5% | 0.4% |
Return vs Industry: 177A underperformed the JP Biotechs industry which returned 30.7% over the past year.
Return vs Market: 177A underperformed the JP Market which returned -0.2% over the past year.
Price Volatility
| 177A volatility | |
|---|---|
| 177A Average Weekly Movement | 6.3% |
| Biotechs Industry Average Movement | 10.0% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in JP Market | 9.4% |
| 10% least volatile stocks in JP Market | 3.1% |
Stable Share Price: 177A has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 177A's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 159 | Takahito Nakamura | www.kohjin-bio.jp |
Kohjin Bio Co., Ltd. manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics. The company offers tissue culture mediums for virus and recombinant protein production, hybridoma, human lymphocyte culture, and insect cell lines; gas permeable cell culture bags and other materials; cryopreservation agent of cells; medium supplements; normal human cells; normal human cell mediums; ES cell mediums; in-vitro fertilization and early embryo culture kits; and other culture and related products, such as supplements, cell separation solutions, physiological salt solutions, and research reagents. The company also offers clinical microbiology culture mediums for gram positive cocci, gram negative bacteria, and susceptibility testing; general differential, anaerobic growth, and fungal mediums; tube mediums for confirmation and expansion; microbiology culture mediums for food, such as mediums for sterilization test, E. coli and coliform bacteria, staphylococcus spp., bacillus cereus, and vibrio parahaemolyticus; culture mediums for determining total viable cell count; and campylobacter and fungal mediums.
Kohjin Bio Co., Ltd. Fundamentals Summary
| 177A fundamental statistics | |
|---|---|
| Market cap | JP¥8.34b |
| Earnings (TTM) | JP¥794.00m |
| Revenue (TTM) | JP¥5.21b |
Is 177A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 177A income statement (TTM) | |
|---|---|
| Revenue | JP¥5.21b |
| Cost of Revenue | JP¥2.84b |
| Gross Profit | JP¥2.37b |
| Other Expenses | JP¥1.57b |
| Earnings | JP¥794.00m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 155.33 |
| Gross Margin | 45.43% |
| Net Profit Margin | 15.25% |
| Debt/Equity Ratio | 35.0% |
How did 177A perform over the long term?
See historical performance and comparisonDividends
Does 177A pay a reliable dividends?
See 177A dividend history and benchmarks| Kohjin Bio dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 30 2025 |
| Days until Ex dividend | 55 days |
| Days until Dividend pay date | 39 days |
Does 177A pay a reliable dividends?
See 177A dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/21 04:39 |
| End of Day Share Price | 2025/05/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kohjin Bio Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyoichiro Shigemura | Nomura Securities Co. Ltd. |